1976
DOI: 10.1136/bmj.1.6015.931
|View full text |Cite
|
Sign up to set email alerts
|

Plasma cyclic adenosine-3', 5'-monophosphate response to glucagon in patients with liver disease.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
8
0

Year Published

1977
1977
1997
1997

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 24 publications
(11 citation statements)
references
References 13 publications
3
8
0
Order By: Relevance
“…The plasma cAMP response is similar to previous studies in normal subjects in our laboratory [Davies et al, 1976]. Intrave nous cAMP and dibutyryl cAMP reduce ADP-induced platelet aggregation, both in vitro [Salzman and Levine, 1971] and in vivo [Zweifler and Sanbar, 1969] affecting both primary and secondary aggregation but only after doses which would produce great er plasma levels than our subjects achieved.…”
Section: Discussionsupporting
confidence: 75%
See 1 more Smart Citation
“…The plasma cAMP response is similar to previous studies in normal subjects in our laboratory [Davies et al, 1976]. Intrave nous cAMP and dibutyryl cAMP reduce ADP-induced platelet aggregation, both in vitro [Salzman and Levine, 1971] and in vivo [Zweifler and Sanbar, 1969] affecting both primary and secondary aggregation but only after doses which would produce great er plasma levels than our subjects achieved.…”
Section: Discussionsupporting
confidence: 75%
“…Glucagon is a potent stimulator of plas ma cAMP, increasing basal levels thirty fold [Davies et al, 1976] and may therefore alter platelet function. In order to determine the influence of glucagon on the primary phase of aggregation we investigated its ef fect in normal subjects before and after pre treatment with aspirin.…”
Section: Introductionmentioning
confidence: 99%
“…It has been known that hepatic reserve can be evaluated by the response of these parameters to glucagon [21 ]. In our study, a significant correlation was demonstrated between the liver glycogen con tent and the increase in the serum glucose after glucagon loading.…”
Section: Discussionsupporting
confidence: 62%
“…Nonetheless, insulin resistance is present in patients with cirrhosis, and this permits augmented gluconeogenesis, ketogenesis (2), and lipolysis during the postabsorptive period. Although there is no evidence for glucagon down-regulation (37)(38)(39), and the hyperglucagonemia accompanying cirrhosis may be needed to facilitate the mobilization of nutrients during fasting (40), it should be recognized that the elevated concentrations of immunoreactive glucagon observed in cirrhotic patients are due to three or four different molecular forms of glucagonlike materials (41). Therefore, it is difficult to be certain about the actual increase in circulating 3,500-D glucagon and the actual biological effects of hyperglucagonemia in cirrhotic patients.…”
Section: Discussionmentioning
confidence: 99%